The correction includes just three lots of Abbott's FreeStyle Libre 3 sensors. The lot numbers are: If you still have the ...

Abbott's FreeStyle Libre CGM systems include sensors ... The key differences between Dexcom and FreeStyle Libre include ...

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed strength in medical devices, sending its shares down more ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

In our view, Abbott's FreeStyle Libre blood glucose monitor franchise ... who wish to monitor their health through a wearable sensor. As with any company involved with medical technology, Abbott ...

CEO Robert Ford said in an earnings call in October that the potential for Abbott's FreeStyle Libre CGM is a “mass market opportunity.” There are about 10 million CGM users worldwide ...

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Omnipod 5 is now available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensor compatibility. Indicated for individuals aged two years and older ...

Libre Drives Diabetes Care: Abbott’s Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.